☆ 4.7 Review

Adverse events following COVID-19 vaccination: A systematic review and meta-analysis

INTERNATIONAL IMMUNOPHARMACOLOGY (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Psychiatry

Loneliness in the presence of others: A mixed-method study of social networks of caregivers of patients with severe mental disorders

Maryam Tabatabaee et al.

Summary: This study investigated the personal support network of caregivers of patients with severe mental illness in Iran. The majority of caregivers had a small network predominantly composed of immediate family members. Caregivers expressed a greater need for economic and instrumental support rather than emotional support, indicating unmet basic needs. Stigma was identified as a significant source of family distress and a barrier to social relationships.

INTERNATIONAL JOURNAL OF SOCIAL PSYCHIATRY (2023)

添加到收藏夹

Review Medicine, General & Internal

Frequency of Adverse Events in the Placebo Arms of COVID-19 Vaccine Trials A Systematic Review and Meta-analysis

Julia W. Haas et al.

Summary: This systematic review and meta-analysis found that significantly more adverse events (AEs) were reported in the vaccine groups compared with the placebo groups, but the rates of reported AEs in the placebo arms were still substantial. Public vaccination programs should take into account the high rates of AEs in placebo arms.

JAMA NETWORK OPEN (2022)

添加到收藏夹

Review Substance Abuse

Public health risks associated with methadone in Iran: A systematic review and meta-analysis

Yasna Rostam-Abadi et al.

Summary: Methadone maintenance treatment (MMT) has shown significant growth in Iran over the past two decades, resulting in positive health outcomes. While non-prescribed use of methadone in the general population is relatively low, there is an increasing trend in methadone-related poisoning and deaths, which poses serious public health concerns.

INTERNATIONAL JOURNAL OF DRUG POLICY (2022)

添加到收藏夹

Article Infectious Diseases

Safety and immunogenicity of SpikoGen®, an Advax-CpG55.2-adjuvanted SARS-CoV-2 spike protein vaccine: a phase 2 randomized placebo-controlled trial in both seropositive and seronegative populations

Payam Tabarsi et al.

Summary: The SpikoGen (R) vaccine has a good safety profile and induces promising immune responses against SARS-CoV-2. Previously infected individuals show a significant immune response after a single dose of the vaccine.

CLINICAL MICROBIOLOGY AND INFECTION (2022)

添加到收藏夹

Article Infectious Diseases

Safety and immunogenicity of an inactivated COVID-19 vaccine, BBIBP-CorV, in people younger than 18 years: a randomised, double-blind, controlled, phase 1/2 trial

ShengLi Xia et al.

Summary: This study evaluated the safety and immunogenicity of the inactivated COVID-19 vaccine BBIBP-CorV in participants aged 3-17 years. The results showed that BBIBP-CorV was safe and well tolerated at all tested dose levels and induced robust antibody responses. Phase 3 trials are recommended in the population younger than 18 years to further assess its safety and protection efficacy against COVID-19.

LANCET INFECTIOUS DISEASES (2022)

添加到收藏夹

Article Medicine, General & Internal

Efficacy, safety, and immunogenicity of the DNA SARS-CoV-2 vaccine (ZyCoV-D): the interim efficacy results of a phase 3, randomised, double-blind, placebo-controlled study in India

Akash Khobragade et al.

LANCET (2022)

添加到收藏夹

Article Immunology

Safety and immunogenicity of NVX-CoV2373 (TAK-019) vaccine in healthy Japanese adults: Interim report of a phase I/II randomized controlled trial

Taisei Masuda et al.

Summary: This study evaluated the safety and immunogenicity of the NVX-CoV2373 vaccine in healthy Japanese participants. The results showed that two doses of NVX-CoV2373 given with a 21-day interval demonstrated acceptable safety and induced robust anti-SARS-CoV-2 immune responses in healthy Japanese adults.

VACCINE (2022)

添加到收藏夹

Editorial Material Endocrinology & Metabolism

Experiences from the management of COVID-19 pandemic in a nursing home in Iran (March-April, 2020)

Shervan Shoaee et al.

Summary: This commentary shares the insights and lessons learned from Kahrizak Charity Foundation (KCF) in managing the COVID-19 outbreak, emphasizing the importance of addressing the higher risk population such as the elderly and those with comorbidities.

JOURNAL OF DIABETES AND METABOLIC DISORDERS (2022)

添加到收藏夹

Review Medicine, General & Internal

The impact of novel coronavirus COVID-19 on noncommunicable disease patients and health systems: a review

Andrew Y. Chang et al.

Summary: This passage highlights the impact of COVID-19 on patients with noncommunicable diseases (NCDs) and the considerations involved. The pandemic has disrupted the screening, treatment, and surveillance of NCD patients, with potential long-term effects on both patients and healthcare providers in the field.

JOURNAL OF INTERNAL MEDICINE (2021)

添加到收藏夹

Article Infectious Diseases

Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial

Shengli Xia et al.

Summary: The inactivated SARS-CoV-2 vaccine, BBIBP-CorV, demonstrated safety and immunogenicity in two age groups. Humoral responses against SARS-CoV-2 were induced in all vaccine recipients by day 42. A two-dose immunisation with 4 mu g vaccine on days 0 and 21 or days 0 and 28 achieved higher neutralising antibody titres compared to other dosing schedules.

LANCET INFECTIOUS DISEASES (2021)

添加到收藏夹

Review Medicine, General & Internal

Maintaining Safety with SARS-CoV-2 Vaccines

Mariana C. Castells et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Review Public, Environmental & Occupational Health

Air travel and COVID-19 prevention in the pandemic and peri-pandemic period: A narrative review

Michel Bielecki et al.

Summary: Air travel during the COVID-19 pandemic faces challenges for travellers, airlines, and authorities, with reduced flights, effective preventive measures like hygiene, mask use, and social distancing, but unreliable temperature screening. The risk of in-flight transmission is low but caution is necessary, with ongoing research needed for evidence-based preventive measures and safety assessments.

TRAVEL MEDICINE AND INFECTIOUS DISEASE (2021)

添加到收藏夹

Article Medicine, General & Internal

Safety and immunogenicity of S-Trimer (SCB-2019), a protein subunit vaccine candidate for COVID-19 in healthy adults: a phase 1, randomised, double-blind, placebo-controlled trial

Peter Richmond et al.

Summary: A study in Australia evaluated the dose-finding and adjuvant justification of the SCB-2019 vaccine against SARS-CoV-2. The vaccine, which contains a stabilised trimeric form of the spike protein (S-Trimer) combined with AS03 or CpG/Alum adjuvants, elicited robust humoral and cellular immune responses in both younger and older adults.

LANCET (2021)

添加到收藏夹

Article Infectious Diseases

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial

Zhiwei Wu et al.

Summary: The study showed that CoronaVac vaccine is safe and well tolerated in older adults, and is able to induce neutralizing antibody levels. The highest dose of 3 μg of the vaccine can generate neutralizing antibody levels similar to the 6 μg dose, supporting the use of the 3 μg dose CoronaVac in phase 3 trials.

LANCET INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Infectious Diseases

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial

Yanjun Zhang et al.

Summary: This study investigated the safety, tolerability, and immunogenicity of the COVID-19 vaccine candidate CoronaVac, and found that the 3 μg dose showed higher seroconversion rates in the phase 2 trial.

LANCET INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Biotechnology & Applied Microbiology

An online survey of the attitude and willingness of Chinese adults to receive COVID-19 vaccination

Musha Chen et al.

Summary: The study found that the majority of Chinese adults were willing to receive a COVID-19 vaccine, with concerns about potential adverse effects. Domestic vaccines were preferred. Lack of confidence, complacency about health, vaccine risk, and attention frequency were the main factors influencing vaccine acceptance.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2021)

添加到收藏夹

Article Dentistry, Oral Surgery & Medicine

Global, regional, and national burden and quality of care index (QCI) of lip and oral cavity cancer: a systematic analysis of the Global Burden of Disease Study 1990-2017

Ahmad Sofi-Mahmudi et al.

Summary: The study aimed to assess the quality of care for lip and oral cavity cancer worldwide using data from the Global Burden of Disease Study 2017. Through principal component analysis, a Quality-of-Care Index (QCI) was determined based on various measures. The results showed continuous improvement in care quality globally from 1990 to 2017, with variations between genders and regions. Alarmingly, some countries, particularly in Africa and Afghanistan, did not experience the same level of improvement as others, highlighting the need for better access to high-quality treatments and preventive measures.

BMC ORAL HEALTH (2021)

添加到收藏夹

Review Infectious Diseases

Effectiveness and safety of SARS-CoV-2 vaccine in real-world studies: a systematic review and meta-analysis

Qiao Liu et al.

Summary: This study included 58 studies, with the effectiveness of a single dose vaccine in preventing SARS-CoV-2 infections at 41% and two doses reaching 85% effectiveness. The vaccines are generally safe and help reduce the incidence of COVID-19-related deaths and severe cases.

INFECTIOUS DISEASES OF POVERTY (2021)

添加到收藏夹

Review Immunology

Efficacy and Safety of COVID-19 Vaccines: A Systematic Review and Meta-Analysis of Randomized Clinical Trials

Ali Pormohammad et al.

Summary: This study systematically reviewed the clinical features of COVID-19 vaccines in clinical trials, finding that mRNA-based and adenovirus-vectored vaccines exhibited different efficacy and side effect profiles. Both types of vaccines showed high efficacy after the first and second doses, with mRNA-based vaccines having higher reported side effects.

VACCINES (2021)

添加到收藏夹

Review Substance Abuse

Buprenorphine abuse and health risks in Iran: A systematic review

Mina Ansari et al.

Summary: The use of buprenorphine maintenance treatment (BMT) in Iran is increasing, but adverse health consequences associated with buprenorphine are less frequent compared to other opioids. The prevalence of non-prescribed buprenorphine use varies among different populations, with overall stability.

DRUG AND ALCOHOL DEPENDENCE (2021)

添加到收藏夹

Article Biotechnology & Applied Microbiology

A comprehensive analysis of the efficacy and safety of COVID-19 vaccines

Changjing Cai et al.

Summary: The numbers of COVID-19 cases and deaths are increasing, with vaccine efficacy exceeding 70% and RNA-based vaccines being the most effective at 94.29%. The most common vaccine-related adverse reactions are pain, fatigue, and headache, with most reactions being mild, although severe reactions such as thromboembolic events have been identified.

MOLECULAR THERAPY (2021)

添加到收藏夹

Article Medicine, General & Internal

Safety and immunogenicity of an mRNA-lipid nanoparticle vaccine candidate against SARS-CoV-2 A phase 1 randomized clinical trial

Peter G. Kremsner et al.

Summary: The RNActive technology platform was used to prepare CVnCoV, a COVID-19 vaccine containing optimized mRNA encoding for a stabilized form of SARS-CoV-2 spike protein. The dosage escalation phase 1 study showed that 12 µg of CVnCoV vaccine elicited immune responses comparable to those seen in convalescent sera from COVID-19 patients, with acceptable safety and reactogenicity.

WIENER KLINISCHE WOCHENSCHRIFT (2021)

添加到收藏夹

Review Infectious Diseases

Safety of SARS-CoV-2 vaccines: a systematic review and meta-analysis of randomized controlled trials

Musha Chen et al.

Summary: A systematic review and meta-analysis found that the safety and tolerance of current COVID-19 vaccine candidates are acceptable for mass vaccination, with inactivated COVID-19 vaccines candidates having the lowest reported adverse events following immunization (AEFI). Long-term surveillance of vaccine safety is required, especially among elderly people with underlying medical conditions.

INFECTIOUS DISEASES OF POVERTY (2021)

添加到收藏夹

Review Nanoscience & Nanotechnology

Lipid nanoparticles for mRNA delivery

Xucheng Hou et al.

Summary: Lipid nanoparticle-mRNA formulations have successfully entered clinical use as COVID-19 vaccines, representing a major milestone in mRNA therapeutics. This review discusses the design of lipid nanoparticles for mRNA delivery, emphasizing key points for clinical translation and preclinical studies of lipid nanoparticle-mRNA therapeutics for various diseases.

NATURE REVIEWS MATERIALS (2021)

添加到收藏夹

Review Immunology

Nervous and Muscular Adverse Events after COVID-19 Vaccination: A Systematic Review and Meta-Analysis of Clinical Trials

Jiaxin Chen et al.

Summary: The study found that NMAEs (nervous and muscular adverse events) after COVID-19 vaccination are common, particularly headache and myalgia. Although these adverse events are mostly mild reactions, continuous monitoring is still necessary during the vaccination process.

VACCINES (2021)

添加到收藏夹

Letter Psychiatry

Discrimination in COVID-19 vaccination programs-A possible risk for mental health

Mina Ansari et al.

ASIAN JOURNAL OF PSYCHIATRY (2021)

添加到收藏夹

Article Medicine, General & Internal

A Novel Coronavirus from Patients with Pneumonia in China, 2019

Na Zhu et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

Article Public, Environmental & Occupational Health

Economic Consequences of the COVID-19 Outbreak: the Need for Epidemic Preparedness

Anton Pak et al.

FRONTIERS IN PUBLIC HEALTH (2020)

添加到收藏夹

Article Medicine, General & Internal

Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes Interim Analysis of 2 Randomized Clinical Trials

Shengli Xia et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

添加到收藏夹

Article Medicine, General & Internal

Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial

Feng-Cai Zhu et al.

LANCET (2020)

添加到收藏夹

Article Medicine, General & Internal

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

Pedro M. Folegatti et al.

LANCET (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults

Mark J. Mulligan et al.

NATURE (2020)

添加到收藏夹

Review Immunology

Potential effects of vaccinations on the prevention of COVID-19: rationale, clinical evidence, risks, and public health considerations

Janet Sultana et al.

EXPERT REVIEW OF VACCINES (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Spotlight on COVID‐19: from biology to therapy and prevention

Serena Zacchigna et al.

FEBS Journal (2020)

添加到收藏夹

Article Medicine, General & Internal

Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates

Edward E. Walsh et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

Article Medicine, General & Internal

Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine

Cheryl Keech et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

Article Medicine, General & Internal

Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial

Maheshi N. Ramasamy et al.

LANCET (2020)

添加到收藏夹

Review Pharmacology & Pharmacy

Immune-mediated adverse reactions to vaccines

Cosby A. Stone et al.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2019)

添加到收藏夹

Article Allergy

Immediate Hypersensitivity to Polyethylene Glycols and Polysorbates: More Common Than We Have Recognized

Cosby A. Stone et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2019)

添加到收藏夹

Review Pharmacology & Pharmacy

mRNA vaccine delivery using lipid nanoparticles

Andreas M. Reichmuth et al.

THERAPEUTIC DELIVERY (2016)

添加到收藏夹

Review Immunology

Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS)

Tom T. Shimabukuro et al.

VACCINE (2015)

添加到收藏夹

Review Medicine, General & Internal

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

David Moher et al.

PLOS MEDICINE (2009)

添加到收藏夹

Article Medicine, Research & Experimental

Random-effects model for meta-analysis of clinical trials: An update

Rebecca DerSimonian et al.

CONTEMPORARY CLINICAL TRIALS (2007)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.